Landthaler M - Search Results

1

A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts.

Meyer S, Fuchs TJ, Bosserhoff AK, Hofstädter F, Pauer A, Roth V, Buhmann JM, Moll I, Anagnostou N, Brandner JM, Ikenberg K, Moch H, Landthaler M, Vogt T, Wild PJ. Meyer S, et al. Among authors: landthaler m. PLoS One. 2012;7(6):e38222. doi: 10.1371/journal.pone.0038222. Epub 2012 Jun 7. PLoS One. 2012. PMID: 22685558 Free PMC article.

2

Tissue microarray analysis of methylthioadenosine phosphorylase protein expression in melanocytic skin tumors.

Wild PJ, Meyer S, Bataille F, Woenckhaus M, Ameres M, Vogt T, Landthaler M, Pauer A, Klinkhammer-Schalke M, Hofstaedter F, Bosserhoff AK. Wild PJ, et al. Among authors: landthaler m. Arch Dermatol. 2006 Apr;142(4):471-6. doi: 10.1001/archderm.142.4.471. Arch Dermatol. 2006. PMID: 16618867

3

Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma.

Meyer S, Wild PJ, Vogt T, Bataille F, Ehret C, Gantner S, Landthaler M, Klinkhammer-Schalke M, Hofstaedter F, Bosserhoff AK. Meyer S, et al. Among authors: landthaler m. Exp Dermatol. 2010 Aug;19(8):e251-7. doi: 10.1111/j.1600-0625.2010.01072.x. Exp Dermatol. 2010. PMID: 20500769 Free article.

4

Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma.

Roesch A, Becker B, Meyer S, Hafner C, Wild PJ, Landthaler M, Vogt T. Roesch A, et al. Among authors: landthaler m. Mod Pathol. 2005 Apr;18(4):565-72. doi: 10.1038/modpathol.3800324. Mod Pathol. 2005. PMID: 15502804 Free article.

5

Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas.

Roesch A, Becker B, Meyer S, Wild P, Hafner C, Landthaler M, Vogt T. Roesch A, et al. Among authors: landthaler m. Mod Pathol. 2005 Sep;18(9):1249-57. doi: 10.1038/modpathol.3800413. Mod Pathol. 2005. PMID: 15803180 Free article.

6

A potential predictive marker for response to interferon in malignant melanoma.

Wild PJ, Meyer S, Landthaler M, Hofstaedter F, Bosserhoff AK. Wild PJ, et al. Among authors: landthaler m. J Dtsch Dermatol Ges. 2007 Jun;5(6):456-9. doi: 10.1111/j.1610-0387.2007.06303.x. J Dtsch Dermatol Ges. 2007. PMID: 17537037 Review. English, German.

7

Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma.

Meyer S, Vogt T, Landthaler M, Berand A, Reichle A, Bataille F, Marx AH, Menz A, Hartmann A, Kunz-Schughart LA, Wild PJ. Meyer S, et al. Among authors: landthaler m. PPAR Res. 2009;2009:848645. doi: 10.1155/2010/848645. Epub 2009 Jul 20. PPAR Res. 2009. PMID: 19639032 Free PMC article.

8

Identification of new genes associated with melanoma.

Mauerer A, Roesch A, Hafner C, Stempfl T, Wild P, Meyer S, Landthaler M, Vogt T. Mauerer A, et al. Among authors: landthaler m. Exp Dermatol. 2011 Jun;20(6):502-7. doi: 10.1111/j.1600-0625.2011.01254.x. Epub 2011 Mar 16. Exp Dermatol. 2011. PMID: 21410771

9

Bullous malignant melanoma: an unusual differential diagnosis of a hemorrhagic friction blister.

Vogt T, Brunnberg S, Hohenleutner U, Landthaler M. Vogt T, et al. Among authors: landthaler m. Dermatol Surg. 2003 Jan;29(1):102-4. doi: 10.1046/j.1524-4725.2003.29005.x. Dermatol Surg. 2003. PMID: 12534522

10

Loss of EphB6 expression in metastatic melanoma.

Hafner C, Bataille F, Meyer S, Becker B, Roesch A, Landthaler M, Vogt T. Hafner C, et al. Among authors: landthaler m. Int J Oncol. 2003 Dec;23(6):1553-9. Int J Oncol. 2003. PMID: 14612926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

751 results

Search Page

Filters